BioCentury | Jan 31, 2011
Financial News

IntelliPharmaCeutics completes private placement of units

...million Units: 4.8 million Price: $2.50 (unit) Shares after offering: 15.7 million Underwriters: Ladenburg Thalmann; Loewen, Ondaatje, McCutcheon...
BioCentury | Nov 22, 2010
Company News

Intellipharmaceutics management update

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI; TSX:I), Toronto, Ontario Business: Drug delivery Hired: Shameze Rampertab as CFO, effective Nov. 29, formerly a partner at Loewen Ondaatje McCutcheon Ltd. WIR Staff...
BioCentury | Feb 9, 2009
Company News

Quest Pharma dermatology, cancer news

...Quest hired Loewen, Ondaatje, McCutcheon Ltd. to assist in a review of strategic alternatives. The company's lead compound...
BioCentury | Jun 4, 2007
Finance

Ebb & Flow

...company Supratek filed for an IPO on the Toronto Stock Exchange through underwriters Dundee Securities; Loewen, Ondaatje, McCutcheon...
BioCentury | May 30, 2007
Financial News

Supratek files for IPO

...Montreal, Quebec) filed for an IPO on the Toronto Stock Exchange underwritten by Dundee Securities; Loewen, Ondaatje, McCutcheon...
BioCentury | Mar 3, 2006
Financial News

Arius raises C$24.6 million

...at C$1. Investors included OrbiMed Advisors; Xmark Opportunity; and Efficacy Capital. Placement agents were Dundee; Loewen, Ondaatje, McCutcheon...
BioCentury | Feb 1, 2006
Financial News

Arius to raise C$22.8 million

...consists of a share plus one five-year warrant exercisable at C$1. Placement agents were Dundee; Loewen, Ondaatje, McCutcheon...
BioCentury | Jan 20, 2006
Financial News

Procyon raises C$18.1M, plans acquisition

...consists of a share plus a five-year warrant exercisable at C$0.35. Placement agents were Dundee; Loewen, Ondaatje, McCutcheon...
BioCentury | Nov 24, 2004
Financial News

Adaltis prices IPO

Diagnostic company Adaltis (TSE:ADS) raised C$55 million (US$46.1 million) in an IPO through the sale of 10 million shares at C$5.50. The deal, which has a 1.5 million share overallotment, was underwritten by National Bank;...
BioCentury | Oct 18, 2004
Finance

Ebb & Flow

...C$20.9 million (US$16.7million) in cash as of June 30. The underwriters are National Bank Financial; Loewen, Ondaatje, McCutcheon...
Items per page:
1 - 10 of 22
BioCentury | Jan 31, 2011
Financial News

IntelliPharmaCeutics completes private placement of units

...million Units: 4.8 million Price: $2.50 (unit) Shares after offering: 15.7 million Underwriters: Ladenburg Thalmann; Loewen, Ondaatje, McCutcheon...
BioCentury | Nov 22, 2010
Company News

Intellipharmaceutics management update

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI; TSX:I), Toronto, Ontario Business: Drug delivery Hired: Shameze Rampertab as CFO, effective Nov. 29, formerly a partner at Loewen Ondaatje McCutcheon Ltd. WIR Staff...
BioCentury | Feb 9, 2009
Company News

Quest Pharma dermatology, cancer news

...Quest hired Loewen, Ondaatje, McCutcheon Ltd. to assist in a review of strategic alternatives. The company's lead compound...
BioCentury | Jun 4, 2007
Finance

Ebb & Flow

...company Supratek filed for an IPO on the Toronto Stock Exchange through underwriters Dundee Securities; Loewen, Ondaatje, McCutcheon...
BioCentury | May 30, 2007
Financial News

Supratek files for IPO

...Montreal, Quebec) filed for an IPO on the Toronto Stock Exchange underwritten by Dundee Securities; Loewen, Ondaatje, McCutcheon...
BioCentury | Mar 3, 2006
Financial News

Arius raises C$24.6 million

...at C$1. Investors included OrbiMed Advisors; Xmark Opportunity; and Efficacy Capital. Placement agents were Dundee; Loewen, Ondaatje, McCutcheon...
BioCentury | Feb 1, 2006
Financial News

Arius to raise C$22.8 million

...consists of a share plus one five-year warrant exercisable at C$1. Placement agents were Dundee; Loewen, Ondaatje, McCutcheon...
BioCentury | Jan 20, 2006
Financial News

Procyon raises C$18.1M, plans acquisition

...consists of a share plus a five-year warrant exercisable at C$0.35. Placement agents were Dundee; Loewen, Ondaatje, McCutcheon...
BioCentury | Nov 24, 2004
Financial News

Adaltis prices IPO

Diagnostic company Adaltis (TSE:ADS) raised C$55 million (US$46.1 million) in an IPO through the sale of 10 million shares at C$5.50. The deal, which has a 1.5 million share overallotment, was underwritten by National Bank;...
BioCentury | Oct 18, 2004
Finance

Ebb & Flow

...C$20.9 million (US$16.7million) in cash as of June 30. The underwriters are National Bank Financial; Loewen, Ondaatje, McCutcheon...
Items per page:
1 - 10 of 22